These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 15881176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 6. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD, Das KM.
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [Abstract] [Full Text] [Related]

  • 7. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK.
    Cochrane Database Syst Rev; 2020 Aug 12; 8(8):CD000543. PubMed ID: 32786164
    [Abstract] [Full Text] [Related]

  • 8. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
    Kao J, Kwok K, Das KM.
    J Clin Gastroenterol; 2010 Sep 12; 44(8):531-5. PubMed ID: 20495466
    [Abstract] [Full Text] [Related]

  • 9. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun 12; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 10. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A, Spinella S, Levenstein S, Prantera C.
    Ital J Gastroenterol; 1994 Apr 12; 26(3):121-5. PubMed ID: 7914759
    [Abstract] [Full Text] [Related]

  • 11. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM, Kushkuley S, Barrett JA, Oster G.
    Aliment Pharmacol Ther; 2012 Aug 12; 36(3):248-56. PubMed ID: 22690748
    [Abstract] [Full Text] [Related]

  • 12. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL, Lakatos L.
    Expert Opin Pharmacother; 2008 Apr 12; 9(5):741-9. PubMed ID: 18345952
    [Abstract] [Full Text] [Related]

  • 13. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD, Woseth DM, Thisted RA, Hanauer SB.
    Am J Gastroenterol; 2000 May 12; 95(5):1263-76. PubMed ID: 10811338
    [Abstract] [Full Text] [Related]

  • 14. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.
    Tokui K, Asai Y, Arakawa T, Matsumoto T, Nabeshima T.
    Biol Pharm Bull; 2002 Feb 12; 25(2):264-7. PubMed ID: 11853180
    [Abstract] [Full Text] [Related]

  • 15. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 12; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 16. [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
    Klugmann HJ, Giehler B, Lohmann D, Schiedewitz W.
    Gastroenterol J; 1990 Jan 12; 49(4):160-4. PubMed ID: 1970478
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G, Carrai M, Venturini G, Gambardella L.
    Minerva Dietol Gastroenterol; 1990 Jan 12; 36(1):31-3. PubMed ID: 1970855
    [Abstract] [Full Text] [Related]

  • 18. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
    Schroeder KW.
    Scand J Gastroenterol Suppl; 2002 Jan 12; (236):42-7. PubMed ID: 12408503
    [Abstract] [Full Text] [Related]

  • 19. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
    Harris MS, Lichtenstein GR.
    Aliment Pharmacol Ther; 2011 May 12; 33(9):996-1009. PubMed ID: 21385194
    [Abstract] [Full Text] [Related]

  • 20. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP.
    Aliment Pharmacol Ther; 2006 Sep 12; 24 Suppl 1():10-6. PubMed ID: 16939424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.